| [1] | Liu J.T.C., Glaser A.K., Bera K., et al. (2021). Harnessing non-destructive 3D pathology. Nat. Biomed. Eng. 5:203−218. DOI:10.1038/s41551-020-00681-x |
| [2] | Glaser A.K., Reder N.P., Chen Y., et al. (2017). Light-sheet microscopy for slide-free non-destructive pathology of large clinical specimens. Nat. Biomed. Eng. 1:0084. DOI:10.1038/s41551-017-0084 |
| [3] | Intoto-Biotech (2024). Patho One & Pano One. https://intotobiotech.com/cpzx |
| [4] | Song A.H., Williams M., Williamson D.F.K., et al. (2024). Analysis of 3D pathology samples using weakly supervised AI. Cell 187:2502-2520. DOI:https://doi.org/10.1016/j.cell.2024.03.035 |
| [5] | Liu Y., Dai Y. and Wang L. (2026). Spatial omics at the forefront: Emerging technologies, analytical innovations, and clinical applications. Cancer Cell 44:24−49. DOI:10.1016/j.ccell.2025.12.009 |
| Xu T., Li J., Qin W., et al. (2026). The revolution of 3D pathology for clinical practice in China. The Innovation Informatics 2:100034. https://doi.org/10.59717/j.xinn-inform.2026.100034 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Concepts and applications of Patho One for 3D pathology